二、关于 2024 年限制性股票激励计划回购价格调整的核查意见 鉴于公司 2024 年年度权益分派的实施，公司将 2024 年限制性股票激励计划 首次授予和暂缓授予回购价格由 5.27 元/股调整至 5.02 元/股，符合《上市公司 股权激励管理办法》和公司《2024 年限制性股票激励计划》等相关规定，并严 格按照相关法律法规履行了必要的审议程序，不存在损害公司及全体股东利益的 情形，我们同意公司本次激励计划回购价格的调整。 浙江台华新材料集团股份有限公司 浙江台华新材料集团股份有限公司 关于第五届监事会第十六次会议相关事项的核查意见 浙江台华新材料集团股份有限公司（以下简称"公司"）监事会根据《中华 人民共和国公司法》、《中华人民共和国证券法》等有关法律、法规和规范性文 件以及《公司 2024 年限制性股票激励计划》（以下简称"《激励计划》"）等 有关规定，对公司第五届监事会第十六次会议审议相关事项进行了核查，现发表 核查意见如下： 一、关于 2024 年限制性股票激励计划首次授予部分第一个解除限售期解除 限售条件成就的核查意见 经核查，公司监事会认为：公司 2024 年限制性股票激励计划首次授予部分 第一 ...

证券代码：603055 证券简称：台华新材 公告编号：2025-058 表决结果：9 票同意、0 票反对、0 票弃权。 （二）审议通过了《关于 2024 年限制性股票激励计划回购价格调整的议案》 浙江台华新材料集团股份有限公司 第五届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 浙江台华新材料集团股份有限公司（以下简称"公司"）第五届董事会第二 十次会议于 2025 年 8 月 13 日在公司会议室以现场结合通讯方式召开，会议通知 已于 2025 年 8 月 8 日以专人送达、电话通知等方式发出。会议应到董事 9 人， 实到董事 9 人。公司监事和部分高级管理人员列席会议。会议由董事长施清岛先 生主持。会议的召集及召开程序符合《公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 经过有效表决，审议通过了以下议案： （一）审议通过了《关于 2024 年限制性股票激励计划首次授予部分第一个 解除限售期解除限售条件成就的议案》 具体内容详见公司披露于上海证券交易所网 ...

证券之星消息，8月11日纺织制造板块较上一交易日上涨0.22%，金春股份领涨。当日上证指数报收于 3647.55，上涨0.34%。深证成指报收于11291.43，上涨1.46%。纺织制造板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 300877 | 金春股份 | 27.99 | 3.94% | | 9.87万 | 2.74亿 | | 600156 | रून में दिस् | 7.44 | 2.62% | | 17.02万 | · 1.25亿 | | 000955 | 欣龙控股 | 5.13 | 2.40% | | 24.27万 | 1.24亿 | | 002042 | 保安时尚 | 5.23 | 2.35% | 78.72万 | | 4.11亿 | | 603130 | 云中马 | 42.34 | 2.30% | | 10.39万 | 4.34亿 | | 301066 | 万事利 | 16.00 | 2.04% | | 4.05万 | 6450.08 ...

Group 1 - The core concept of the article revolves around the identification and investment in "super strong stocks" that possess evolutionary capabilities and long-term growth potential, as emphasized by Kenneth Fisher's idea of "super strong stocks" [1][2] - The manager, Duan Tao, has significantly increased the allocation to Hong Kong stocks in his fund, particularly focusing on innovative pharmaceutical companies, indicating a keen awareness of market trends [2][3] - The performance of the fund, particularly in the innovative pharmaceutical sector, has been outstanding, with a reported annual return of 76.19% as of August 5, significantly outperforming the benchmark [1][2] Group 2 - Duan Tao's investment strategy is characterized by a bottom-up approach, focusing on small and mid-cap growth stocks, which he has been researching since entering the public fund industry in 2015 [4][5] - The fund's portfolio is diversified across various sectors, with a notable focus on the healthcare industry, including medical devices and services, which are seen as having substantial growth potential [3][4] - The selection methodology employed by Duan Tao includes evaluating companies based on four dimensions: good business, good company, good price, and catalysts, which helps in identifying strong investment opportunities [7][8]

Core Points - The company is holding a shareholders' meeting on August 13, 2025, to ensure the rights of shareholders and maintain order during the meeting [1][4] - The meeting will include a proposal to elect a new independent director, Mr. Fu Guangwei, to replace the outgoing independent director, Mr. Wang Rui, who has served for the maximum term of six years [6][7] Meeting Procedures - A meeting organization team will be established, and only authorized personnel will be allowed to enter the venue [1] - Shareholders must arrive 15 minutes before the meeting to sign in and present relevant documents [2] - Shareholders have the right to speak, inquire, and vote, with a time limit of five minutes for each speaker [2] - Voting will be conducted through both on-site and online methods, with specific instructions provided for online voting [3] - The results of the voting will be announced by the host after completion [6] Independent Director Nomination - Mr. Fu Guangwei has been nominated as the independent director candidate and has no existing shares in the company or relationships with major shareholders [7] - His qualifications have been approved by the Shanghai Stock Exchange [7] - A detailed resume of Mr. Fu Guangwei highlights his extensive experience in the textile industry and various leadership roles [8]

证券代码：603055 证券简称：台华新材 公告编号：2025-057 浙江台华新材料集团股份有限公司 关于全资子公司为母公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 本次担保金额 | 10,000 | 万元 | 浙江台华新材料集团股份有限公司 | | --- | --- | --- | --- | --- | | 担保对象 | 实际为其提供的担保余额 | 30,000 | 万元 | | | | 是否在前期预计额度内 | 是 | □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 435,598.11 | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 86.18 | | 100% 特别风险提示 ...

浙江台华新材料集团股份有限公司 2025 年第二次临时股东大会 会议材料 二〇二五年八月 目录 | 2025 年第二次临时股东大会会议须知 | 3 | | --- | --- | | 2025 年第二次临时股东大会会议议程 | 5 | | 议案：关于补选独立董事的议案 | 6 | 2 浙江台华新材料集团股份有限公司 2025 年第二次临时股东大会会议须知 一、本次股东大会设立会务组，由董事会办公室负责有关程序方面的事宜。 二、为保证股东大会的正常秩序，除出席会议的股东或者股东代理人、董事、 监事、高级管理人员、见证律师及董事会邀请的人员外，公司有权依法拒绝其他 人员进入会场。 三、出席会议的股东须在会议召开前 15 分钟到达会议现场向工作人员办理 签到手续，并请按规定出示相关证件和文件，经验证后领取会议资料，方可出席 会议。 四、股东参加股东大会依法享有发言权、质询权、表决权等各项权利。股东 要求在股东大会上发言，可在签到时先向会务组登记，会上由主持人统筹安排股 东发言。为了保证会议的高效率，发言或提问应围绕本次会议议题进行，简明扼 要，每位股东发言时间原则上不超过 5 分钟。发言时应先报告姓名和所持股份数 ...

Group 1 - The stock price of Taihua New Materials remained stable at 9.71 yuan as of the market close on August 5, 2025, with a total market capitalization of 8.645 billion yuan [1] - The company specializes in the research and production of nylon new materials, primarily serving the textile, apparel, and outdoor equipment sectors [1] - Domestic sales are the main focus of the company's business, with overseas sales accounting for 12.93% in 2024, targeting markets in Southeast Asia, South Asia, and the European Union [1] Group 2 - On August 5, the net outflow of main funds was 1.5842 million yuan, with a cumulative net outflow of 21.3056 million yuan over the past five days [1]

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问贵公司自2023年以来是否出口欧盟国家？ 台华新材（603055.SH）8月5日在投资者互动平台表示，尊敬的投资者，您好！公司业务以国内销售为 主，2024年度境外销售占比为12.93%，境外销售有东南亚、南亚、欧盟等地区，感谢您对公司的关 注！ ...

Core Viewpoint - The company focuses on the research and production of nylon 6, nylon 66, and environmentally friendly recycled nylon products, indicating a commitment to innovation and sustainability in the textile industry [1] Company Overview - The main products of the company include nylon filament, grey fabric, and functional finished fabrics, which are utilized in various sectors such as apparel, home textiles, industrial applications, and special applications [1] - The characteristics of nylon, including lightweight, high strength, wear resistance, and flexibility, suggest potential applications in the field of humanoid robotics [1]